Docoh
Loading...

24 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
of the Company or any of its subsidiaries is represented by a union and, to the knowledge of the Company, no union organizing activities are taking
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
Union member states as then-currently constituted; provided, however, that the EU shall always be deemed to include the Major European Countries. 1.19
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
drug status in the European Union, or EU, has similar, but not identical, requirements and benefits. Expedited review and approval The FDA has … . European Union Drug Development Similar to the United States, the various phases of preclinical and clinical research in the European Union are subject
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”), nor (2 … bargaining agreement with any union and no organization efforts are underway with respect to employees of the Company or its subsidiary. As used
424B4
9tovd2b 7ayjd6blryg3
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
xt8ot9lekelnhuggwao
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
65w9e143elffg
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-1.1
sjc2zkhf
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
fur si2mux
17 Jul 20
IPO registration (amended)
5:25pm
10-K
g0tu1h8
5 Mar 20
Annual report
7:00pm
S-1
2eam2f 30r4iibjut
13 Dec 19
IPO registration
5:32pm
10-K/A
4wp0lfjp95y8ofyz vt
5 Apr 19
Annual report (amended)
9:40pm
10-K
tpkwyeq
28 Mar 19
Annual report
5:25pm
424B3
sxoxop6
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
3nq r6973
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
cqznh
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
ei6y05gnwl
13 Sep 18
IPO registration (amended)
8:00pm
S-1
zt2qm8y17 1xe
29 Jul 18
IPO registration
8:00pm
10-K/A
b6mlmjs2hx
16 Apr 18
Annual report (amended)
8:00pm